Versant Venture Capital V (Canada), LP

10% owner at Turnstone Biologics Corp. · on record since Jul 27, 2023
10% owner at CRISPR Therapeutics AG · on record since Oct 26, 2016
10% owner at Gritstone bio, Inc. · on record since Sep 27, 2018
10% owner at Crinetics Pharmaceuticals, Inc. · on record since Jul 20, 2018
general partner at Gritstone bio, Inc. · on record since Oct 2, 2018
10% owner at Aprea Therapeutics, Inc. · on record since Oct 7, 2019
10% owner at Repare Therapeutics Inc. · on record since Jun 25, 2020

Insider trading activity of Versant Venture Capital V (Canada), LP

Transactions on record: 37; since Dec 23, 2016

Open-market buys: 4; $2.3M

Open-market sells: 0

Companies traded: 2; last filing Jun 3, 2021

Figures computed from official regulatory filings — .

Companies where Versant Venture Capital V (Canada), LP has traded

Repare Therapeutics Inc.5 tx · Jun 3, 2021
CRISPR Therapeutics AG32 tx · $2.3M · Dec 23, 2016

Track record of Versant Venture Capital V (Canada), LP

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Versant Venture Capital V (Canada), LP

Co-insiders of Versant Venture Capital V (Canada), LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Repare Therapeutics Inc.Listing unverified	Jun 3, 2021	Other	1,119	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	Jun 3, 2021	Other	1,128	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	Jun 3, 2021	Other	-1,119	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	Jun 3, 2021	Other	-1,128	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	Jun 3, 2021	Other	-75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-13,180	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	2,754	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-168,224	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	437,247	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-231,077	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-1,454	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-3,100,477	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	73,704	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	231,077	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-2,210,417	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-5,210	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Buy	602	14.00 USD	$8.4K	conv 42ClusterFirst in 12mo	SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Buy	95,596	14.00 USD	$1.3M	conv 42ClusterFirst in 12mo	SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	168,224	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	5,210	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-173,167	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Buy	4,583	14.00 USD	$64.2K	conv 42ClusterFirst in 12mo	SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	173,167	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Buy	60,219	14.00 USD	$843.1K	conv 42ClusterFirst in 12mo	SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	5,774	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Repare Therapeutics Inc.Listing unverified	Jun 3, 2021	Other	1,119	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	Jun 3, 2021	Other	1,128	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	Jun 3, 2021	Other	-1,119	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	Jun 3, 2021	Other	-1,128	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Repare Therapeutics Inc.Listing unverified	Jun 3, 2021	Other	-75,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-13,180	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	2,754	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-168,224	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	437,247	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-231,077	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-1,454	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-3,100,477	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	73,704	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	231,077	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-2,210,417	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-5,210	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Buy	602	14.00 USD	$8.4K	conv 42ClusterFirst in 12mo	SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Buy	95,596	14.00 USD	$1.3M	conv 42ClusterFirst in 12mo	SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	168,224	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	5,210	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	OtherD (derivative)	-173,167	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Buy	4,583	14.00 USD	$64.2K	conv 42ClusterFirst in 12mo	SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	173,167	—	n/a (No price was disclosed in the filing)		SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Buy	60,219	14.00 USD	$843.1K	conv 42ClusterFirst in 12mo	SEC
CRISPR Therapeutics AGListing on record	Dec 23, 2016	Other	5,774	—	n/a (No price was disclosed in the filing)		SEC